Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries.
about
Mycotoxins and human disease: a largely ignored global health issueThe exposome: from concept to utilityRisk factors for hepatocellular carcinoma in IndiaBiomonitoring Human Albumin Adducts: The Past, the Present, and the FutureGlobal geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwideAdvances in chemical carcinogenesis: a historical review and prospectiveAssessment of mycotoxin risk on corn in the Philippines under current and future climate change conditions.Nrf2: friend or foe for chemoprevention?Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylationHealth economic impacts and cost-effectiveness of aflatoxin-reduction strategies in Africa: case studies in biocontrol and post-harvest interventionsEvaluating the technical feasibility of aflatoxin risk reduction strategies in AfricaCosts and efficacy of public health interventions to reduce aflatoxin-induced human diseaseGlobal burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.Contribution of gut bacteria to liver pathobiology.Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians.Aflatoxin regulations in a network of global maize trade.Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sexPrenatal exposure of mice to the human liver carcinogen aflatoxin B1 reveals a critical window of susceptibility to genetic change.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.DNA Sequence Modulates Geometrical Isomerism of the trans-8,9- Dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)- 9-hydroxy Aflatoxin B1 AdductAflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.Aflatoxin regulations and global pistachio trade: insights from social network analysis.Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali.Occurrence of aflatoxins in selected processed foods from PakistanPresent and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.A single neonatal exposure to aflatoxin b1 induces prolonged genetic damage in two loci of mouse liver.Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa.Global risk assessment of aflatoxins in maize and peanuts: are regulatory standards adequately protective?AFB(1) -induced mutagenesis of the gpt gene in AS52 cells.Biomarkers in population studies: environmental mutagenesis and risk for cancer.Aflatoxin B1 inhibits the type 1 interferon response pathway via STAT1 suggesting another mechanism of hepatocellular carcinomaThe impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma.The evolving epidemiology of hepatocellular carcinoma: a global perspective.Projections of primary liver cancer to 2030 in 30 countries worldwide.A Review of the Current Situation of Aflatoxin M1 in Cow's Milk in Serbia - Risk Assessment and Regulatory Aspects.Therapeutic properties of green tea against environmental insults.Dietary Exposure and Natural Occurrence of Total Aflatoxins in Basmati Rice of Pakistan.Mycotoxin Contamination of Rice in China.Application of Probabilistic Modeling to Quantify the Reduction Levels of Hepatocellular Carcinoma Risk Attributable to Chronic Aflatoxins Exposure.Aflatoxin biomarkers in hair may facilitate long-term exposure studies.
P2860
Q24650056-886DD9A5-3D4F-4FD8-8999-447A055BFB9DQ26821776-D18093C4-8F2F-4720-B51F-2655CF9E2D2FQ26830794-5D24E41F-0794-4480-82CC-83C5857BA4B9Q28468289-CE75D809-41BC-4CDF-9D77-B5BAE391E3B2Q28706340-57FC5917-F149-4CA3-BF9C-7E86EB3F5227Q28756544-B434FECB-D11E-4BB3-8DA8-91C38603ACCCQ30992300-4442EB79-0D52-4CF8-9819-2F6C72BFD3FDQ33575690-8A3E0C50-512F-417C-A4F4-FCA05AD6CC43Q33575712-5A1DA0F4-0148-4233-A95D-55ADDD0FB2A6Q33805854-3790B1EA-9BA2-4AF4-AB43-0979CD561CA2Q33901917-CACAAC7F-857A-4082-AB6C-15A464DF6100Q33912791-CDA9AC71-D1F3-4FE5-BBD8-54B0E39CBE55Q33969253-508FAC0F-9CB4-4E65-A78C-B5612FA0D793Q34035372-0137ABB7-E2DC-4B0E-A397-17A17DB80679Q34422414-6ACD8A7F-A768-43AB-8DBD-672926898E66Q34438001-D1AC4FED-8E85-4FB0-9B10-0B60CB782C0DQ34824342-200CA585-95F8-4A7A-9B17-55CDFFA36B93Q34898887-4EB04D15-F431-4E6F-8467-755C06E88360Q35015993-DFD86302-9D83-4A01-84F6-9134242F2D3BQ35093833-6853CAD0-8D77-40A1-8F0D-A2FE6098324CQ35127694-1C60C9A7-E9B6-4AB9-97B7-C6CEB8A60039Q35131967-EAEF9804-C6AB-4F4D-9DD5-E8AF86C93CDEQ35492635-041A4E22-A318-4230-A35D-5B32625252C9Q36197196-5A6A2F0D-AE0B-45E4-895F-97008E1C58BAQ36318656-45435882-55D5-48EA-98C3-0AB21A23AEFEQ36383643-4491AA4C-905E-44D1-813B-12D5B6992197Q36992263-6676E65B-6662-4BE5-A9CF-7EA5CD26125AQ37108808-8140AE0C-B6F3-4CE4-A774-819D7EAA8D84Q37498621-B0E639D3-8FE8-4E41-A3A4-EFE4CB169D7FQ37573672-663B9768-A9AA-4777-B387-1A4BD1AA796FQ37713659-5E0B755E-6416-4732-A2FA-EF05212E24C7Q38193582-11DB1E81-7B97-4A6E-9274-BB3FBD8DE679Q38397998-79A30B67-22D7-4D0A-BA20-E6E638673F2AQ38634903-BA3FDACA-CF9C-4496-8F8E-7FFC28F28088Q38637316-B9748239-4DE6-4E49-9458-378013A06282Q38813046-0AD02F4B-FFDE-4B20-9867-3931BB23A6B6Q38950192-897843AE-5A9E-4FEC-B197-E7045F1B354BQ39109545-FD389040-72C1-43D1-A98D-AEAB1F7DDF5EQ39130039-31BE568F-F520-4332-931C-62463BF55E69Q39281969-1CAD8EC9-2ED9-43DC-83D3-DB5A57ACCF8A
P2860
Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Protective interventions to pr ...... nesis in developing countries.
@ast
Protective interventions to pr ...... nesis in developing countries.
@en
Protective interventions to pr ...... nesis in developing countries.
@nl
type
label
Protective interventions to pr ...... nesis in developing countries.
@ast
Protective interventions to pr ...... nesis in developing countries.
@en
Protective interventions to pr ...... nesis in developing countries.
@nl
prefLabel
Protective interventions to pr ...... nesis in developing countries.
@ast
Protective interventions to pr ...... nesis in developing countries.
@en
Protective interventions to pr ...... nesis in developing countries.
@nl
P2093
P1476
Protective interventions to pr ...... nesis in developing countries.
@en
P2093
Christopher P Wild
John D Groopman
Thomas W Kensler
P304
P356
10.1146/ANNUREV.PUBLHEALTH.29.020907.090859
P577
2008-01-01T00:00:00Z